Henry Hiep Vo

Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors

Apostolia M. Tsimberidou, Philip Beer, Carrie Cartwright et al. · Clinical Cancer Research · 2021 · 61 citations · Full text

Precision Oncology: Evolving Clinical Trials across Tumor Types

I-Wen Song, Henry Hiep Vo, Ying‐Shiuan Chen et al. · Cancers · 2023 · 57 citations · Full text

Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors

Apostolia M. Tsimberidou, Henry Hiep Vo, Vivek Subbiah et al. · The Oncologist · 2021 · 44 citations · Full text

Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group

Elena Fountzilas, Sofia Lampaki, Georgia-Angeliki Koliou et al. · Cancer Immunology Immunotherapy · 2021 · 39 citations · Full text

AKT inhibition in the central nervous system induces signaling defects resulting in psychiatric symptomatology

Apostolia M. Tsimberidou, Antonis Skliris, Alan Valentine et al. · Cell & Bioscience · 2022 · 21 citations · Full text